All Insights
Exploring the science, practice, and business of medicine.
Exploring the science, practice, and business of medicine.
Showing 8 out of 68 Insights
Mara Bloom, JD, MS, the executive director of Mass General Cancer Center, discusses the future of cancer care delivery, grappling with cost, and access to clinical trials.
Linnea Olson, a lung cancer activist and blogger, discusses terms of respect, patient-centered drug development, and online patient communities.
Justin F. Gainor, MD, director of targeted immunotherapy at Massachusetts General Hospital and assistant professor of medicine at Harvard Medical School, answers three questions about cancer immunotherapy.
Elaine B. Goodman, MD, MBA, medical director of the Medical Walk-In Unit at Massachusetts General Hospital and associate chief medical officer at Wellframe, discusses sustained engagement and impact for digital health solutions.
David M. Levine, MD, MPH, MA, a physician and researcher at Brigham and Women’s Hospital, discusses potential gains and obstacles for home hospital.
Michael Chernew, director of the Healthcare Markets and Regulation Lab at Harvard Medical School, discusses intersections between approaches to slowing health care spending and real-world experience.
Kenneth Mandl, MD, MPH, director of the Computational Health Informatics Program at Boston Children's Hospital, discusses opportunities, limits, and hurdles for health care data apps.
Ateev Mehrotra, MD, MPH, associate professor of healthcare policy at Harvard Medical School discusses striking growth and potential savings in telehealth.